Related Experiment Video
Updated: Mar 1, 2026

Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
Cardiac amyloidosis: a challenging diagnosis
Graziele Cristina Palancio Morais1, Marjorie Moreira Arruda1, José Carlos de Aguiar Bonadia1
1Department of Pathological Sciences - Faculdade de Ciências Médicas - Santa Casa de Misericórdia de São Paulo - São Paulo/SP - Brazil.
Insights
Cardiac amyloidosis, often AL amyloidosis, severely impacts heart function and prognosis. This case highlights severe cardiac involvement in systemic amyloidosis, diagnosed posthumously.
Area of Science:
- Cardiology
- Pathology
- Internal Medicine
Background:
- Amyloidosis frequently affects the heart (90% of cases), particularly AL amyloidosis.
- Cardiac manifestations include restrictive cardiomyopathy and conduction abnormalities (up to 50%).
- Cardiac involvement significantly worsens prognosis in systemic amyloidosis.
Observation:
- The study presents a case of primary systemic amyloidosis.
- Severe cardiac involvement was a key feature of this case.
- Diagnosis was established only upon autopsy.
Findings:
- Autopsy revealed extensive cardiac infiltration by amyloid.
- The patient presented with clinical signs of heart failure and conduction disturbances.
- The case underscores the diagnostic challenges of cardiac amyloidosis.
Implications:
- Highlights the critical role of early diagnosis for improving patient outcomes.
- Emphasizes the need for increased awareness among clinicians regarding cardiac amyloidosis.
- Suggests autopsy can reveal the full extent of cardiac involvement in systemic diseases.
Abstract:
Cardiovascular involvement of amyloidosis is present in 90% of cases, which is frequently associated with the primary form of the disease (AL amyloidosis). Clinical manifestations are represented by heart failure due to restrictive myocardiopathy and electrical impulse conduction abnormalities, which are clinically remarkable in up to 50% of the cases. The prognosis of patients with systemic amyloidosis is directly associated with the presence of cardiac involvement, such that survival does not usually exceed 4 months after the onset of heart failure signs and symptoms. The authors report a case of primary systemic amyloidosis, diagnosed only at autopsy, with severe cardiac involvement.
More Related Videos
10:04Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
Published on: October 20, 2017
08:31Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management